Cutting-Edge Translational Pathology and Target Discovery Services for Pharmaceutical and Biotech Companies.

Cancer Target-Discover for Pharma (CanTar®-Discover for Pharma LLC) is a specialized consultancy in pathology that emphasizes discovery and translational pathology services tailored for pharmaceutical companies. Our expertise enables us to facilitate the advancement of innovative therapeutic solutions through rigorous pathological analysis and insights. We encourage you to explore our exceptional services and delve into our profound expertise in cancer targets. Your journey towards understanding innovative CanTar® solutions starts here!

CanTar® delivers world-class scientific expertise in translational pathology, digital image analysis, and biomarker discovery. We partner with pharmaceutical companies to accelerate drug development through rigorous, evidence-based pathology solutions from preclinical research through clinical trials. We bridge the gap between preclinical discovery and clinical development by providing comprehensive pathology expertise, advanced digital image analysis, and strategic support. Our mission is to accelerate the development of transformative therapies by delivering precise, reliable, and scientifically rigorous pathology insights.

"Empowering Your Cancer Target Discovery with Dependable Service and Support!" We support throughout the life cycle of Cancer Target Discovery and Translational Pathology Services. CanTar® is committed to empowering the pharmaceutical industry to reach its goals through our unparalleled expertise and innovative solutions. Let us partner with you to drive success and make a significant impact in your endeavors.